AMISH : Aprovel for Management of Isolated Systolic Hypertension

Phase 4 Completed 436 enrolled Sanofi Bristol-Myers Squibb · collab

RandomizedParallel-groupOpen-labelTreatment

Summary

To compare the antihypertensive efficacy and tolerability of irbesartan and irbesartan-hydrochlorothiazide fixed combination therapy with amlodipine and amlodipine plus hydrochlorothiazide in the treatment of isolated systolic hypertension.

Timeline

Start: 2004-08
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Irbesartan	Small molecule	—	—
Subject	irbesartanhydrochlorothiazide	Unknown	—	—

AMISH : Aprovel for Management of Isolated Systolic Hypertension

Summary

Timeline

Drugs

Indications